Triad Group plc (LON:TRD)

Verve Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 7, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	47	54	40	23	23	20
Market Cap Growth	36.89%	36.89%	73.58%	-1.53%	15.57%	373.13%
Enterprise Value	44	52	38	19	18	17
Last Close Price	2.70	3.20	2.30	1.28	1.23	1.06
PE Ratio	27.30	31.32	-	-	19.81	29.25
PS Ratio	2.20	2.53	2.82	1.54	1.36	1.13
PB Ratio	9.70	11.18	11.64	4.39	3.85	3.79
P/TBV Ratio	9.70	11.18	11.64	4.39	3.85	3.80
P/FCF Ratio	21.81	25.12	-	33.78	21.72	15.69
P/OCF Ratio	21.19	24.41	-	33.34	19.33	15.24
EV/Sales Ratio	2.06	2.42	2.70	1.26	1.08	0.94
EV/EBITDA Ratio	21.13	26.62	-	153.26	15.50	21.88
EV/EBIT Ratio	23.49	27.59	-	534.21	16.60	24.43
EV/FCF Ratio	20.49	24.08	-	27.70	17.26	13.12
Debt / Equity Ratio	0.11	0.11	0.22	0.20	0.07	0.14
Debt / EBITDA Ratio	0.26	0.26	-	3.41	0.31	0.78
Debt / FCF Ratio	0.25	0.25	-	1.55	0.40	0.57
Asset Turnover	2.84	2.84	1.85	1.69	1.96	2.19
Quick Ratio	2.14	2.14	2.03	2.84	3.17	2.91
Current Ratio	2.20	2.20	2.10	2.90	3.23	2.95
Return on Equity (ROE)	41.96%	41.96%	-23.58%	-0.78%	20.69%	13.93%
Return on Assets (ROA)	15.57%	15.57%	-10.51%	0.25%	7.99%	5.27%
Return on Capital (ROIC)	24.67%	24.67%	-15.37%	0.34%	11.12%	7.45%
Return on Capital Employed (ROCE)	35.10%	35.10%	-	0.60%	17.30%	11.60%
Earnings Yield	3.68%	3.19%	-2.56%	-0.19%	5.05%	3.42%
FCF Yield	4.59%	3.98%	-3.87%	2.96%	4.60%	6.37%
Dividend Yield	2.22%	1.87%	2.61%	4.70%	4.87%	1.88%
Payout Ratio	57.80%	57.80%	-	-	55.86%	-
Buyback Yield / Dilution	-5.42%	-5.42%	-0.21%	0.29%	-2.75%	-1.24%
Total Shareholder Return	-3.22%	-3.54%	2.40%	4.99%	2.12%	0.65%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.